Bio-Rad Laboratories BIO Europe — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's europe — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's europe — net sales?
- Bio-Rad Laboratories (BIO) reported europe — net sales of $206.8M in Q1 2026.
- How has Bio-Rad Laboratories's europe — net sales changed year-over-year?
- Bio-Rad Laboratories's europe — net sales increased by 3.5% year-over-year, from $199.8M to $206.8M.
- What is the long-term trend for Bio-Rad Laboratories's europe — net sales?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's europe — net sales has grown at a -1.8% compound annual growth rate (CAGR), from $947M to $881.8M.
- What does europe — net sales mean?
- The total revenue earned from customers located in the European region.
- How do you interpret europe — net sales?
- An increase suggests successful market expansion, higher product demand, or favorable pricing, while a decrease may indicate competitive pressure, reduced research funding, or economic headwinds in Europe.
- How does europe — net sales compare across companies?
- Comparable to regional revenue reporting by global life science and diagnostics peers, often benchmarked against regional GDP growth and healthcare spending trends.